Welcome to the annual meeting for LB Pharmaceuticals Inc. Our host for today's call is Heather Turner, CEO. I will now turn the call over to your host. Ms. Turner, you may begin. Good morning. I'm very happy to welcome you to the LB Pharmaceuticals Inc's 2026 Stockholders Meeting. The meeting will now officially come to order. The time is now 9:30 A.M. on June 3rd, 2026, and the polls are now open for voting on all matters to be presented. As you know, we are hosting today's meeting through a virtual online platform hosted by Broadridge Financial Solutions Inc. Before we proceed with the formal business of the meeting, I'd like to introduce to you the members of the board and the business team who are with us today. The other members of the board with us virtually today are Scott Garland, Rekha Hemrajani, Will Kane, Dr. Robert Lenz, Rebecca Luse, and Dr. Robert Ruffolo. The other officers and executives of the company with us virtually today are Gad Soffer, Chief Operating Business Officer, Kaya Pai Panandiker, Chief Commercial Officer, Minako Pazdera, General Counsel, Marc Panoff, Senior Vice President of Finance, Richard Silva, Senior Vice President, Technical Operations, Ellen Rose, Senior Vice President, Corporate Affairs, Lindsay Beaupre, Senior Vice President of People and Culture, and James Rawls, Senior Vice President of Regulatory Affairs. I would also like to introduce JT Scheriff and [Justin Halperin] of BDO USA, P.C., the company's independent registered public accounting firm, and Minkyu Park, Cooley LLP, the company's legal counsel, who are also in attendance virtually. We will proceed with the formal business of the meeting in the order set forth in the notice of annual meeting and proxy statement. We will present the two proposals submitted for approval by our board. We will take questions related to the proposals or any questions for the auditors after all of the proposals have been presented, after which we will announce the preliminary results of the voting. The polls are open for voting on all matters to be presented. Each share of common stock is entitled to one vote. After I describe each item to be voted on, we will close the polls. We will not accept ballots, proxies, revocations, or changes after the closing of the polls. If you have already submitted your vote by proxy and do not wish to change your vote, you do not need to vote now, and your shares will be counted as previously instructed. If you intend to vote and have not already done so, you must submit your vote online now in order for it to be counted. If you have not voted, I encourage you to vote online now. The rules of conduct for this meeting are posted in the Meeting Materials section of the virtual meeting platform. In order to conduct an orderly meeting, we ask that you follow these rules. Stockholders who are attending this meeting with a valid 16-digit control number may submit questions or comments for the Q&A portion of this meeting through the text box located on the virtual meeting screen. We will try to answer questions submitted that are germane to the proposals and or this meeting, as and if we have time. Please note that our discussion today may include forward-looking statements and our actual results may differ materially from those discussed here. Additional information concerning factors that could cause such a difference can be found in our most recently filed quarterly report on Form 10-Q. Minako Pazdera will act as secretary of this meeting. Will the secretary please report at this time with respect to the mailing of the notice of the meeting? I have at this meeting a complete list of the holders of record of the company's common stock on April 7th, 2026, the record date of this meeting. I also have an affidavit certifying that notice of this annual meeting of stockholders of the company was duly given to all stockholders of record at the close of business on April 7th, 2026. A copy of the notice and affidavit will be filed with the records of the meeting. At this time, I'd like to introduce Richard Kretz of Broadridge Financial Solutions, Inc., who is present virtually. Richard has been appointed to act as Inspector of Election at this meeting. Richard has taken and subscribed the customary oath of office to execute his duties with strict impartiality. We will file this oath with the records of the meeting. Will the secretary please report at this time with respect to the existence of a quorum? I have been informed by the Inspector of Election that proxies have been received for 23,284,217 of the 28,675,637 shares of common stock outstanding on the record date, which represents approximately 81.19% of the total number of outstanding shares. This constitutes a quorum for the meeting today, and we may now carry out the official business of the meeting. We will now proceed with the formal business of this meeting. After all of the proposals have been described, we will answer any questions related to the proposals submitted online. As a reminder, we ask that any comments or questions during this portion of the meeting pertain only to these proposals. Please submit any questions as soon as possible for our review. There are two proposals to be considered by the stockholders at this meeting. The first item of business is the election of three Class I directors to serve until the 2029 annual meeting and their successors are elected. The nominees for Class I director are Dr. Robert Lenz, Rebecca Luse, and Ran Nussbaum. The second item of business today is the ratification of the appointment by the Audit Committee of the Board of Directors of BDO USA P.C., a s the independent registered public accounting firm of the company for the fiscal year ending 2026. That was the final proposal for today's meeting. We will now review if there are any questions submitted about the proposals or addressed to the auditors before we close the polls. As a reminder, we will only review and answer questions that pertain to the proposals. Are there any questions? No questions have been submitted. There are no further questions. The time is now 9:36 A.M., and the polls are now closed for voting. May we have the results of the voting? The report of the Inspector of Election covering the proposals presented at this meeting is as follows. Number one, Dr. Robert Lenz, Rebecca Luse, and Ran Nussbaum have been elected as Class I directors of the company. Number two, the appointment of BDO USA, P.C. as the company's independent registered public accounting firm for the fiscal year ending December 31st, 2026 is ratified. We expect to report our preliminary voting results, or if available to us on a timely basis, our final voting results on a current report on Form 8-K to be filed with the SEC within four business days after the end of this meeting. If not earlier reported, we expect to report our final voting results in an amendment to our Form 8-K within four business days after the final results are known to us. This concludes the formal portion of today's meeting. Thank you for your attendance at today's meeting and for your continued support of LB Pharmaceuticals Inc. It appears we're all set. Thank you again for your attendance today and your continued support. This now concludes the meeting. Thank you for joining and have a pleasant day.